Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
FLNA
$0.47
+4.38%
FLNA
· Filana Therapeutics, Inc.
Market Cap
$22.52M
Shares
50.27M
Volume · Nov 12
432.53K
Avg daily vol (3M)
2.01M
All webcasts
Earnings call · FY2024 Q2
Filana Therapeutics, Inc. (FLNA) Q2 2024 Earnings Call
Diluted EPS
$0.13
Net income
$6.16M
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 8, 2024.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Cash at year-end
year-end 2024
|
$117M – $127M | — |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 8, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 8, 2024 · complete as-filed document